Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases

Abstract Background Vaccine hesitancy has been a growing challenge for public health in recent decades. Among factors contributing to vaccine hesitancy, concerns regarding vaccine safety and Adverse Events (AEs) play the leading role. Moreover, cognitive biases are critical in connecting such concer...

Full description

Bibliographic Details
Published in:	BMC Public Health
Main Authors:	Hossein Azarpanah, Mohsen Farhadloo, Rustam Vahidov, Louise Pilote
Format:	Article
Language:	English
Published:	BMC 2021-09-01
Subjects:	Vaccine hesitancy Adverse event Adverse events following immunization (AEFI) Cognitive bias Vaccine adverse event reporting system (VAERS)
Online Access:	https://doi.org/10.1186/s12889-021-11745-1

Similar Items

ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
by: Roop Sharma, et al.
Published: (2025-05-01)

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review
by: Xiaoying Gong, et al.
Published: (2024-12-01)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021-10-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
by: WANG Qian, et al.
Published: (2022-04-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
by: AbdulAzeez Adeyemi Anjorin, et al.
Published: (2022-04-01)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018-08-01)

Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01)

Surveillance of psychogenic adverse events following immunization in Zhejiang, China, 2020–2023
by: Xuejiao Pan, et al.
Published: (2025-04-01)

Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
by: Cyril N. A. Nyankerh, et al.
Published: (2022-06-01)

Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
by: Hui Liang, et al.
Published: (2025-01-01)

Adverse Events Following Immunization with DTP Vaccine in Infants and Children in Kermanshah City: A Cohort Study
by: M Karami, et al.
Published: (2006-02-01)

Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS)
by: Zhuocheng Bao, et al.
Published: (2025-12-01)

Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior
by: Sujoy Bose, et al.
Published: (2025-07-01)

Vaccines and sudden infant death: An analysis of the VAERS database 1990–2019 and review of the medical literature
by: Neil Z. Miller
Published: (2021-01-01)

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015
by: Elaine R. Miller, et al.
Published: (2018-08-01)

Vaccine hesitancy ‘outbreaks’: using epidemiological modeling of the spread of ideas to understand the effects of vaccine related events on vaccine hesitancy
by: Alison B. Wiyeh, et al.
Published: (2018-12-01)

Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019-03-01)

Characteristics and Comparison of Adverse Events of Coronavirus Disease 2019 Vaccines Reported to the United States Vaccine Adverse Event Reporting System Between 14 December 2020 and 8 October 2021
by: Chenyu Zou, et al.
Published: (2022-04-01)

Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Assessment of Causality, Severity and Seriousness of Adverse Event Following Immunization in Iraq: A Retrospective Study Based on Iraqi
by: Ahmad K. Abd, et al.
Published: (2019-12-01)

Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016
by: Penina Haber, et al.
Published: (2018-11-01)

Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review
by: Fátima Gauna, et al.
Published: (2025-12-01)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021-12-01)

Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose
by: Po-Yu Chen, et al.
Published: (2022-07-01)

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data
by: Yi Cai, et al.
Published: (2017-07-01)

Utilizing group-based models to identify adverse event patterns after an intervention
by: Wei Wang, et al.
Published: (2025-09-01)

Vaccine-associated Arthus reaction
by: Tanatorn Soravipukuntorn, MD, et al.
Published: (2023-09-01)

Factors influencing influenza vaccination coverage among kindergarten and primary school children in Zhejiang Province， 2023
by: LI Minchao, et al.
Published: (2025-01-01)

Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome
by: Madhuri Sankaranarayanapillai, et al.
Published: (2024-01-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
by: Li Sun, et al.
Published: (2024-12-01)

A Cross-Sectional Study to Assess mRNA-COVID-19 Vaccine Safety among Indian Children (5–17 Years) Living in Saudi Arabia
by: Marya Ahsan, et al.
Published: (2023-01-01)

Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
by: Katharine Valéria Saraiva Hodel, et al.
Published: (2024-06-01)

Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
by: Monika Raethke, et al.
Published: (2025-07-01)

Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021
by: Ly Khanh Thi Le, et al.
Published: (2024-02-01)

COVID-19 Vaccination Reporting and Adverse Event Analysis in Taiwan
by: Wan-Chung Hu, et al.
Published: (2024-05-01)

Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China
by: Yiqing Zhu, et al.
Published: (2025-12-01)

Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017
by: Vera Lúcia Gattás, et al.
Published: (2018-12-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)